These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 36163119)
21. Bone marrow microenvironment: The guardian of leukemia stem cells. Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368 [TBL] [Abstract][Full Text] [Related]
22. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934 [TBL] [Abstract][Full Text] [Related]
23. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer. Wang GP; Qi ZH; Chen FP Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667 [TBL] [Abstract][Full Text] [Related]
24. Cellular and Molecular State of Myeloid Leukemia Stem Cells. Xie X; Feng M; Wang Q; Wang J; Yin R; Li Y; Zhang H Adv Exp Med Biol; 2019; 1143():41-57. PubMed ID: 31338814 [TBL] [Abstract][Full Text] [Related]
25. Regulation of hematopoietic and leukemic stem cells by the immune system. Riether C; Schürch CM; Ochsenbein AF Cell Death Differ; 2015 Feb; 22(2):187-98. PubMed ID: 24992931 [TBL] [Abstract][Full Text] [Related]
26. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
28. Leukemia Stem Cells Microenvironment. Tabe Y; Konopleva M Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827 [TBL] [Abstract][Full Text] [Related]
29. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
30. Understanding of leukemic stem cells and their clinical implications. Wang X; Huang S; Chen JL Mol Cancer; 2017 Jan; 16(1):2. PubMed ID: 28137304 [TBL] [Abstract][Full Text] [Related]
31. [Progress in the studies of acute myelogenous leukemia stem cell]. Cui JW; Zhang XM; Wang GJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558 [TBL] [Abstract][Full Text] [Related]
32. Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cells. Velasco-Hernandez T; Trincado JL; Vinyoles M; Closa A; Martínez-Moreno A; Gutiérrez-Agüera F; Molina O; Rodríguez-Cortez VC; Ximeno-Parpal P; Fernández-Fuentes N; Petazzi P; Beneyto-Calabuig S; Velten L; Romecin P; Casquero R; Abollo-Jiménez F; de la Guardia RD; Lorden P; Bataller A; Lapillonne H; Stam RW; Vives S; Torrebadell M; Fuster JL; Bueno C; Sarry JE; Eyras E; Heyn H; Menéndez P Hemasphere; 2024 Feb; 8(2):e45. PubMed ID: 38435427 [TBL] [Abstract][Full Text] [Related]